Snowball logo
logo
XTNT

Xtant Medical Holdings Inc

XTNT โ€ข NYSE MKT
$0.2751-$0.0072ย  (2.55%)
Estimate
EPS
-0.08
Beta
-0.151
Growth
Revenue, YoY
-34.96%
Net income, YoY
-365.15%
FCF, YoY
-930.22%
Forecast
EPS (FWD)
-0.03
About the company
Ticker
XTNT
ISIN
US98420P3082
Country
United States of America
Sector (GICS)
Healthcare
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers cervical products comprising Spider cervical plating, Streamline OCT system, and CervAlign systems; thoracolumbar products, such as of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; Silex sacroiliac joint fusion systems; interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; Contact ALP (Anterior Lumbar Plate) System; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. The company is headquartered in Belgrade, Montana.

Frequently asked questions

What sector does Xtant Medical Holdings Inc (XTNT) operate in?

Xtant Medical Holdings Inc belongs to the Healthcare sector and operates in the Medical Devices industry.

What is Xtant Medical Holdings Inc (XTNT) current stock price?

As of the latest data, Xtant Medical Holdings Inc stock price is $0.28, with a previous close of $0.28. Xtant Medical Holdings Inc lost -$0.01 in the last trading session, representing a -2.55% loss.

What is Xtant Medical Holdings Inc (XTNT) current market capitalization?

Xtant Medical Holdings Inc market cap is approximately 38.59 million.

What is Xtant Medical Holdings Inc (XTNT) Earnings Per Share (EPS)?

The trailing EPS is -$0.08, and the forward EPS is -$0.03.

What is Xtant Medical Holdings Inc (XTNT) EBITDA?

Xtant Medical Holdings Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -8.29 million.

Does Xtant Medical Holdings Inc (XTNT) pay dividends?

No. Xtant Medical Holdings Inc does not pay a dividend.

How did Xtant Medical Holdings Inc (XTNT) perform in its most recent earnings report?

In the last report (June 30, 2026), Xtant Medical Holdings Inc posted an EPS surprise of -250% and a revenue surprise of -7.41%.

What is Xtant Medical Holdings Inc (XTNT) beta (volatility) score?

Xtant Medical Holdings Inc has a beta of -0.151, indicating lower volatility than the overall market.